Skip to main content
. 2022 Nov 22;23(23):14537. doi: 10.3390/ijms232314537

Figure 2.

Figure 2

SARS-CoV-2 replication rate in the lungs of control (A) and Riamilovir (B) groups: (A) saline, 20 mL/kg, intraperitoneal, daily from 3 to 7 days after infection; (B) Riamilovir, 20 mg/kg, intraperitoneal, daily from 3 to 7 days after infection. Reprinted/adapted with permission (CC BY 3.0) from Ref. [76]. 2021, Chepur S.V. et al.